Aspirin Management for Elective Hernia Repair
For most patients undergoing elective inguinal hernia repair, aspirin should be continued perioperatively without interruption, as the risk of thrombotic complications outweighs the minimal increase in bleeding risk.
Primary Recommendation
The 2024 AHA/ACC guidelines explicitly state that in patients with coronary artery disease (CAD) undergoing noncardiac surgery, it is recommended to continue aspirin (75-100 mg) if possible to reduce the risk of cardiac events 1. This Class 1, Level B recommendation represents the highest level of guidance and should direct clinical decision-making for hernia repair.
Risk Stratification Approach
Continue Aspirin (Preferred Strategy)
- Patients with prior PCI (stents): Aspirin continuation is mandatory unless bleeding risk is prohibitive 1
- Secondary cardiovascular prevention: Patients with history of MI, stroke, or peripheral arterial disease benefit from continued aspirin 2
- Standard inguinal hernia repair: Recent high-quality evidence demonstrates that continuing aspirin during hernia repair does not increase hematoma formation, reoperation rates, or wound complications 3, 4, 5
Consider Discontinuation (Rare Scenarios)
Only for procedures with exceptionally high bleeding risk (e.g., neurosurgery), aspirin should be stopped for 5 days to ensure complete platelet function recovery 2. Standard hernia repair does not meet this threshold.
Evidence Supporting Continuation
The 2025 CAPTAIN trial—the most recent randomized controlled trial—found no difference in hematoma formation between aspirin continuation versus cessation groups (3.3% vs 2.9%, p=1.000) in laparoscopic hernia repair 3. A 2024 meta-analysis of 344 patients confirmed no significant difference in overall hemorrhage rates (OR: 1.86,95% CI: 0.29-11.78, p=0.130) 4.
Multiple studies consistently demonstrate:
- No increase in intraoperative blood loss 6, 5
- Similar operative times 5, 7
- Comparable wound complications 3, 6
- No difference in reoperation rates 4, 7
Timing Considerations
If aspirin must be discontinued (against standard recommendations):
- Stop 3 days before surgery for standard procedures 2
- Stop 5 days before surgery only for high-bleeding-risk procedures 2
- Resume aspirin as soon as possible postoperatively, ideally the same day if hemostasis is adequate 2
Critical Pitfalls to Avoid
Do not routinely discontinue aspirin for hernia repair: The thrombotic risk (MI, stroke) significantly exceeds bleeding risk in patients with cardiovascular indications 1, 2
Beware of withdrawal syndrome: Discontinuing aspirin increases risk of recurrent ischemic stroke or cardiovascular events by approximately 2% within 30 days 2
Distinguish aspirin from P2Y12 inhibitors: Clopidogrel, prasugrel, and ticagrelor require longer discontinuation periods (5-7 days) if cessation is necessary 2
Avoid bridging with heparin: Do not bridge aspirin with LMWH or UFH—this increases bleeding risk without reducing thrombotic events 2
Special Populations
Patients with recent stents:
- Continue aspirin regardless of hernia repair timing 1
- If dual antiplatelet therapy (DAPT) is required, delay elective surgery until DAPT can be safely interrupted (typically 6-12 months post-stent) 1
Primary prevention patients: Even in lower-risk patients, the ASINC trial showed aspirin reduced major cardiac events by 80% without excess bleeding in noncardiac surgery 2
Practical Algorithm
- Identify cardiovascular indication: Prior PCI, CAD, stroke, or peripheral arterial disease → Continue aspirin
- Assess bleeding risk: Standard hernia repair (open or laparoscopic) = low-moderate bleeding risk → Continue aspirin
- Document decision: Note continuation in operative plan and communicate with anesthesia
- Postoperative management: Resume immediately if any interruption occurred
The evidence overwhelmingly supports aspirin continuation for hernia repair, with guideline-level recommendations prioritizing cardiac protection over minimal bleeding concerns 1, 2.